Ascorbic Acid, Calcium Carbonate, Calcium Lactate Gluconate

3 trials AGastroenterology

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

0 Recruiting

3 Completed trials

2 Sponsors

9 Countries

Phase III

Phase II

Phase I/II

Phase III: 1 Phase II: 1 Phase I/II: 1

Indications tested

Obesity 1 Overweight 1 Osteoporosis postmenopausal 1

Sponsors using this IMP

AstraZeneca AB 2 Curateq Biologics Private Limited 1

All trials

3 total

A Phase I/II, Randomised, Single-blind, Placebo-controlled, Multiple-ascending-dose Study to Evaluate the Safety, Tolerability, Pharmacokine… Ended

2023-504215-32-00 Phase I/II 3 countries AstraZeneca AB
A weight loss study evaluating subcutaneous treatment withAZD9550 and AZD6234 in combination, against placebo or each of the drugs alone Ended

2024-516176-15-00 Phase II 1 country AstraZeneca AB
Efficacy, safety, PK, PD, and immunogenicity of BP16 in post-menopausal osteoporosis Ended

2023-503790-37-00 Phase III 6 countries Curateq Biologics Private Limited

Showing 1–3 of 3 trials

← All drugs A–Z